# Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye

> **NCT07679685** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Beijing Tongren Hospital** · enrollment: 159 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** 0.1% Sodium Hyaluronate Eye Drops
- **DRUG:** Perfluorohexyloctane Eye Drops (PFHO)

## Key facts

- **NCT ID:** NCT07679685
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-04-30
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07679685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07679685, "Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07679685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*